Share on StockTwits

Minerva Neurosciences (NASDAQ:NERV) major shareholder Care Capital Iii Llc bought 737,500 shares of Minerva Neurosciences stock in a transaction dated Monday, July 7th. The shares were purchased at an average price of $6.00 per share, for a total transaction of $4,425,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Shares of Minerva Neurosciences (NASDAQ:NERV) traded down 0.67% on Wednesday, hitting $5.93. 43,059 shares of the company’s stock traded hands. Minerva Neurosciences has a 52 week low of $5.75 and a 52 week high of $6.38. The stock’s 50-day moving average is $5.99 and its 200-day moving average is $5.99. The company’s market cap is $108.4 million.

Minerva Neurosciences, Inc is a biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (NASDAQ:NERV), diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.